Maria-Luisa Maccecchini - Jan 18, 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Henry Hagopian III, Attorney-in-Fact for Maria L. Maccecchini
Stock symbol
ANVS
Transactions as of
Jan 18, 2023
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 04:43 PM
Previous filing
Oct 24, 2022
Next filing
Feb 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +21.3K $0.00 21.3K Jan 18, 2023 Common Stock 21.3K $13.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight consecutive quarterly installments of 2,664 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.